LG

Leland Gershell

#44 out of 660 analysts
Oppenheimer
Automatically Tracked
Tracking: 0 Updated: 15 minutes ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
133.49%
Gain +1.07%
Monthly
1.23%
Yearly
15.75%
Drawdown
58.72%
$1.82M
Equity
Holdings
$1.62M
Cash
$202,860.34
Investment
$1.37M
$1.09M
Profit +$19,279.67
Realized
$837,674.12
Unrealized
$249,483.5
Dividends
$0
$202,860.34
Cash
Deposits
$737,666.36
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.07%
Profit
$19,279.67
Win %
64%
This Week
Compared To Last Week
Gain
1.07%
Profit
$19,279.67
Win %
64%
This Month
Compared to last month
Gain
0.62%
Profit
$11,258.56
Win %
63%
This Year
Compared to last year
Gain
-2.72%
Profit
-$51,032.57
Win %
60%
enGene Therapeutics Inc. logo
ENGN enGene Therapeutics Inc.
+8.03%
+$9,378.82
NuCana plc ADR logo
NCNA NuCana plc ADR
+5.13%
-$42.32
Protara Therapeutics Inc. logo
TARA Protara Therapeutics Inc.
+2.82%
+$3,296.46
Veru Inc. logo
VERU Veru Inc.
+2.29%
+$2,676.43
Crinetics Pharmaceuticals Inc. logo
CRNX Crinetics Pharmaceuticals Inc.
+1.79%
+$2,087.53
Ocugen Inc. logo
OCGN Ocugen Inc.
+1.65%
+$1,931.81
Urogen Pharma Ltd. logo
URGN Urogen Pharma Ltd.
+0.62%
+$729.48
Soleno Therapeutics, Inc. logo
SLNO Soleno Therapeutics, Inc.
0%
$0
argenx SE American Depositary Receipt logo
ARGX argenx SE American Depositary Receipt
-0.42%
-$493.66
Dianthus Therapeutics Inc. logo
DNTH Dianthus Therapeutics Inc.
-0.25%
-$289.94
Climb Biotherapeutics, Inc. logo
CLYM Climb Biotherapeutics, Inc.
-0.13%
-$153.24
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
1334
Longs Won
779/1317 59%
Profit Factor
2.1
Profitability
Shorts Won
17/17 100%
Standard Deviation
$5,983.04
Average Win
$2,682.29
Best Trade
(Oct 03) $86,679.06
Sharpe Ratio
-473.36
Average Loss
-$1,892.36
Worst Trade
(May 15) -$52,682.71
Z-Score
-8.4 (100%)
Commissions
$0
Avg. Trade Length
2m 6d
Expectancy
$814.96
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.02%
Consecutive Losing Trades 964 868 771 675 579 482 386 289 193 96
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV